# Tibbling Technologies: Redmond AI Profile — Product, Footprint & Verified Record

- **Canonical Web Article:** https://tygartmedia.com/tibbling-technologies-redmond-wa-ai-profile/
- **Profile Brief (PDF):** https://tygartmedia.com/wp-content/uploads/2026/11/tibbling-technologies-redmond-wa-ai-profile.pdf
- **Markdown Twin:** https://tygartmedia.com/wp-content/uploads/2026/11/tibbling-technologies-redmond-wa-ai-profile.md
- **Snapshot Infographic:** https://tygartmedia.com/wp-content/uploads/2026/11/tibbling-technologies-redmond-wa-ai-profile-infographic.png
- **Verified Date:** 2026-11-19

> **Sourced Baseline:** As of November 19, 2026, Tibbling Technologies operates an active research and company website at tibbtech.com detailing its multimodal NeuroAI platform, peer-reviewed publications, and NIH SBIR grant work. The company completed Plug and Play Seattle's third accelerator cohort in mid-2026 and has not publicly disclosed an institutional venture round or acquisition.

## Verified Company Record

| Field | Verified Record (As of Nov 19, 2026) |
| :--- | :--- |
| **Company** | Tibbling Technologies |
| **Official Website** | https://tibbtech.com/ |
| **Washington HQ** | Redmond, WA (federal NIH SBIR grant records); listed as Seattle, WA in Plug and Play Seattle Batch 3 |
| **Other WA Footprint** | Plug and Play Seattle at UW CoMotion Labs (Seattle, WA) and SNBL Global Gateway (Everett, WA); Allen Institute High-Impact Data Challenge (Seattle, WA) |
| **Founded** | Not publicly disclosed (published company research updates date to at least October 2024) |
| **Founders / Leadership** | Asim Iqbal (Founder & CEO) |
| **Stage** | Accelerator (NIH SBIR Grant-Backed) |
| **Announced Funding** | $400,000 non-dilutive NIH SBIR grant (August 2026); no institutional VC round publicly disclosed |
| **Team Size** | Not publicly disclosed |
| **Primary Ecosystem Ties** | Plug and Play Seattle (Batch 3, Mar-Jun 2026); Allen Institute; NVIDIA Inception Program (May 2026) |

## What Tibbling Technologies Builds

Tibbling Technologies is a research-driven NeuroAI and scientific discovery company building biologically grounded multimodal AI systems for neuroscience, spatial biology, medical imaging, and health tech. In [GeekWire's March 23, 2026 announcement](https://www.geekwire.com/2026/10-startups-chosen-for-plug-and-plays-third-seattle-area-accelerator-cohort/) of Plug and Play Seattle's third cohort, the accelerator described Tibbling Technologies as focused on advanced multimodal AI systems solving complex problems in health tech and neuroscience.

On its [official website](https://tibbtech.com/), Tibbling Technologies presents a research-first portfolio spanning brain-inspired neural architectures, biomedical imaging tools, and clinical health applications. Its work includes neocortex-inspired computational primitives mapped to neuromorphic hardware to improve vision transformer compute efficiency—published in a peer-reviewed paper in the Proceedings of the National Academy of Sciences (PNAS)—as well as an [NIH](https://www.nih.gov/) SBIR-funded AI platform for real-time assessment of drug disorders.

- **Drug-disorder assessment platform:** Backed by a $400,000 non-dilutive NIH SBIR grant announced in August 2026 to develop an AI system for real-time assessment of drug disorders.
- **Neuroscience and therapeutic discovery tools:** Includes AAV enhancer discovery for targeted neuronal therapeutics, automated brain-wide neuron segmentation (Segment AnyNeuron), domain-agnostic 3D brain registration across species and modalities (NeuReg on [arXiv](https://arxiv.org/)), and brainstem-targeting motor circuit discovery.
- **Biologically grounded architectures and applied health models:** Covers neuromorphic multimodal sensing for compute-efficient transformers, personalized sports and rehabilitation diagnostics (ExerAIde), behavioral analysis (AnimalFormer), and technical assurance frameworks for brain-inspired computation (Regulating NeuroAI).

## Washington Footprint and Leadership

Public records place Tibbling Technologies in the Greater Seattle area with a transparent city-level nuance across primary sources: federal [National Institutes of Health](https://www.nih.gov/) SBIR grant records and scientific affiliations list **Redmond, Washington** on the Eastside, while [Plug and Play Seattle's Batch 3 announcement](https://www.geekwire.com/2026/10-startups-chosen-for-plug-and-plays-third-seattle-area-accelerator-cohort/) listed the startup as based in **Seattle**. During the 12-week spring 2026 Plug and Play program, cohort founders had access to Plug and Play's Seattle office inside UW's CoMotion Labs and space at SNBL Global Gateway in Everett, showcasing at UW's Kane Hall on June 5, 2026. The company's site also records participation with Seattle's Allen Institute for its High-Impact Data Challenge in August 2025.

Tibbling Technologies is led by Founder & CEO **Asim Iqbal**, a NeuroAI and computational neuroscience researcher focused on brain-inspired computing and deep learning architectures. Company updates on [tibbtech.com](https://tibbtech.com/) highlight collaborations with researchers at institutions including Burke Neurological Institute (BNI) and Weill Cornell Medicine, alongside earlier work co-authored with researchers from Harvard Medical School and the Broad Institute, and co-organizing a NeuroAI workshop at AAAI in Singapore in January 2026. Readers locating the firm online should note that tibbtech.com (resolving to www.tibbtech.com) is the active official website, whereas tibbling.com displays only a minimal 12-byte placeholder.

## Products, Users, and Public Traction

Tibbling Technologies serves life sciences researchers, neuroscience laboratories, healthcare organizations, and medical imaging teams rather than mass-market software buyers. Its public track record on [tibbtech.com](https://tibbtech.com/) emphasizes peer-reviewed publications, scientific preprints, and research collaborations rather than off-the-shelf SaaS pricing or commercial seat metrics.

Notable verified milestones include its August 2026 **$400,000 NIH SBIR grant** award, acceptance into the **NVIDIA Inception Program** in May 2026, participation in the **Allen Institute High-Impact Data Challenge** in August 2025, and a July 2026 research update describing how its AI platform assisted researchers at Burke Neurological Institute and Weill Cornell Medicine in identifying a brainstem-targeting motor circuit relevant to stroke and spinal cord injury recovery. Named commercial enterprise customers, revenue figures, founding year, and team headcount are not publicly disclosed.

## Funding, Stage, and Place in Washington's AI Landscape

Tibbling Technologies is an accelerator- and grant-backed startup. Its verified funding consists of a **$400,000 non-dilutive NIH SBIR grant** reported in August 2026, alongside acceptance into [Plug and Play Seattle Batch 3](https://www.geekwire.com/2026/10-startups-chosen-for-plug-and-plays-third-seattle-area-accelerator-cohort/) (March to June 2026) and [Plug and Play Tech Center's](https://www.plugandplaytechcenter.com/) startup network. No institutional venture capital equity round or acquisition has been publicly announced through November 2026.

Within Washington's life-sciences and health-AI cluster, Tibbling Technologies stands out for grounding its multimodal models in computational neuroscience and neuromorphic efficiency—bridging Puget Sound's research anchor at the Allen Institute and UW corridor with Eastside Redmond operations. It operates alongside Seattle-area peers applying AI to physiological foundation models, live-cell imaging, and autonomous drug discovery.

## Related Washington AI Profiles & Tygart Media Context

- [PreemptiveAI — Seattle AI Profile](https://tygartmedia.com/preemptiveai-seattle-wa-ai-profile/)
- [Clockwork Bio — Seattle AI Profile](https://tygartmedia.com/clockwork-bio-seattle-wa-ai-profile/)
- [Polybiomics — Seattle AI Profile](https://tygartmedia.com/polybiomics-seattle-wa-ai-profile/)
- [Why AI Compute Needs a Warranty, Not Another Watermark](https://tygartmedia.com/certified-compute-warranty-not-watermark/)

## Verified Primary Sources

- [Tibbling Technologies Official Website](https://tibbtech.com/)
- [GeekWire — Plug and Play Seattle Batch 3 (Mar 23, 2026)](https://www.geekwire.com/2026/10-startups-chosen-for-plug-and-plays-third-seattle-area-accelerator-cohort/)
- [Plug and Play Tech Center](https://www.plugandplaytechcenter.com/)
- [National Institutes of Health (NIH)](https://www.nih.gov/)
- [arXiv Preprint Archive](https://arxiv.org/)

## Frequently Asked Questions

### Is Tibbling Technologies based in Redmond or Seattle?

Both cities appear in primary sources across the Greater Seattle metro: federal NIH SBIR grant records list Redmond, Washington, while Plug and Play Seattle's Batch 3 cohort announcement listed the company in Seattle, with accelerator access at UW CoMotion Labs.

### How is Tibbling Technologies funded?

Tibbling Technologies received a $400,000 non-dilutive National Institutes of Health (NIH) SBIR grant announced in August 2026 to build an AI platform for real-time assessment of drug disorders. No institutional venture capital round has been publicly disclosed.

### What is Tibbling Technologies' official website?

The company's active official website is tibbtech.com (resolving to www.tibbtech.com). The domain tibbling.com serves only a minimal placeholder string, while tibbling.ai and tibblingtechnologies.com do not resolve.
